NeurAxis (NRXS) Competitors $2.40 -0.17 (-6.61%) (As of 01:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends NRXS vs. APYX, MLSS, OM, APT, MODD, CTSO, NXL, NTRB, ICAD, and LUCDShould you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include Apyx Medical (APYX), Milestone Scientific (MLSS), Outset Medical (OM), Alpha Pro Tech (APT), Modular Medical (MODD), Cytosorbents (CTSO), Nexalin Technology (NXL), Nutriband (NTRB), iCAD (ICAD), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. NeurAxis vs. Apyx Medical Milestone Scientific Outset Medical Alpha Pro Tech Modular Medical Cytosorbents Nexalin Technology Nutriband iCAD Lucid Diagnostics Apyx Medical (NASDAQ:APYX) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk. Do institutionals and insiders hold more shares of APYX or NRXS? 55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 16.8% of Apyx Medical shares are held by insiders. Comparatively, 15.2% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer APYX or NRXS? Apyx Medical received 77 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% NeurAxisOutperform Votes1100.00% Underperform VotesNo Votes Do analysts prefer APYX or NRXS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67NeurAxis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, APYX or NRXS? Apyx Medical has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.15, meaning that its share price is 315% more volatile than the S&P 500. Which has higher valuation & earnings, APYX or NRXS? NeurAxis has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$48.54M1.32-$18.71M-$0.83-2.05NeurAxis$2.46M6.82-$14.63M-$1.84-1.30 Is APYX or NRXS more profitable? Apyx Medical has a net margin of -58.59% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-58.59% -137.98% -36.74% NeurAxis -492.76%N/A -641.25% Does the media refer more to APYX or NRXS? In the previous week, NeurAxis had 3 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for NeurAxis and 0 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.16 beat NeurAxis' score of 0.39 indicating that Apyx Medical is being referred to more favorably in the media. Company Overall Sentiment Apyx Medical Positive NeurAxis Neutral SummaryApyx Medical beats NeurAxis on 10 of the 17 factors compared between the two stocks. Ad Porter & CompanyForbes rich list released… #1 to be assassinated?Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXS vs. The Competition Export to ExcelMetricNeurAxisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.52M$3.04B$5.14B$9.31BDividend YieldN/A1.73%4.81%4.06%P/E Ratio-1.3418.46135.3117.54Price / Sales7.0054.581,215.74139.37Price / CashN/A39.9140.5837.95Price / Book-9.133.754.884.92Net Income-$14.63M$90.26M$118.89M$225.78M7 Day Performance-4.46%-3.87%16.99%-1.58%1 Month Performance-20.48%2.12%16.58%6.67%1 Year Performance12.05%8.57%35.26%22.48% NeurAxis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXSNeurAxisN/A$2.40-6.6%N/A+19.1%$16.75M$2.46M-1.3419APYXApyx Medical2.7323 of 5 stars$1.78+5.7%N/A-30.2%$66.82M$48.54M-2.23270Positive NewsGap UpMLSSMilestone Scientific1.7973 of 5 stars$0.84+3.7%$1.25+48.8%+46.8%$65.44M$8.88M-11.5730OMOutset Medical2.6767 of 5 stars$1.10-0.9%$4.50+309.1%-83.3%$57.79M$130.38M0.00520APTAlpha Pro TechN/A$5.22-0.6%N/A-2.8%$57.42M$59.29M14.19120MODDModular Medical3.5498 of 5 stars$1.54-3.1%$5.00+224.7%-11.1%$53.42MN/A-2.5239Positive NewsCTSOCytosorbents2.5733 of 5 stars$0.96-5.0%$2.00+108.3%-52.6%$52.49M$33.79M-2.81186Short Interest ↑NXLNexalin Technology1.2356 of 5 stars$3.90-1.5%$3.00-23.1%+815.8%$50.16M$162,078.00-6.193Positive NewsNTRBNutriband0.473 of 5 stars$4.39+6.0%N/A+75.7%$48.76M$2.02M-5.8310Positive NewsGap UpICADiCAD0.3167 of 5 stars$1.82-6.6%N/A+21.8%$48.33M$18.94M-15.0067LUCDLucid Diagnostics2.5045 of 5 stars$0.81+3.2%$3.63+347.3%-38.4%$48.10M$4.19M-0.6970High Trading Volume Related Companies and Tools Related Companies Apyx Medical Alternatives Milestone Scientific Alternatives Outset Medical Alternatives Alpha Pro Tech Alternatives Modular Medical Alternatives Cytosorbents Alternatives Nexalin Technology Alternatives Nutriband Alternatives iCAD Alternatives Lucid Diagnostics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRXS) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXS Stock Alerts